Skip to content

Liver fibrosis

Ramon A. Bataller, David A. Brenner

Journal of Clinical Investigation · 2005 · 5,221 citationsOpen access

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Bataller, R. A., & Brenner, D. A. (2005). Liver fibrosis. Journal of Clinical Investigation, 115(2), 209–218. https://doi.org/10.1172/jci24282

In text: (Bataller & Brenner, 2005)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

Liver fibrosis is the excessive accumulation of extracellular matrix proteins including collagen that occurs in most types of chronic liver diseases. Advanced liver fibrosis results in cirrhosis, liver failure, and portal hypertension and often requires liver transplantation. Our knowledge of the cellular and molecular mechanisms of liver fibrosis has greatly advanced. Activated hepatic stellate cells, portal fibroblasts, and myofibroblasts of bone marrow origin have been identified as major collagen-producing cells in the injured liver. These cells are activated by fibrogenic cytokines such as TGF-beta1, angiotensin II, and leptin. Reversibility of advanced liver fibrosis in patients has been recently documented, which has stimulated researchers to develop antifibrotic drugs. Emerging antifibrotic therapies are aimed at inhibiting the accumulation of fibrogenic cells and/or preventing the deposition of extracellular matrix proteins. Although many therapeutic interventions are effective in experimental models of liver fibrosis, their efficacy and safety in humans is unknown. This review summarizes recent progress in the study of the pathogenesis and diagnosis of liver fibrosis and discusses current antifibrotic strategies.

  1. Preoperative assessment of liver function: a comparison of 99mTc‐Mebrofenin scintigraphy with indocyanine green clearance test2004
  2. Design and validation of a histological scoring system for nonalcoholic fatty liver disease†2005
  3. Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis1996
  4. Nonalcoholic Fatty Liver Disease2002
  5. Wound Healing--Aiming for Perfect Skin Regeneration1997

Metadata from OpenAlex (CC0). Citations are generated from the published record.